Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin May 22, 2025 0

Article Summary : “Treat AFib ‘Diagnosed’ by Smartwatch?” by Dr. F. Perry Wilson

Article Summary :
“Treat AFib ‘Diagnosed’ by Smartwatch?” by Dr. F. Perry Wilson
Published: May 6, 2025
Source: Medscape Commentary
Key Summary Points
1. Changing Diagnosis Pathway:
• AFib was traditionally diagnosed via symptoms → clinic visit → EKG.
• Now, many diagnoses are triggered by smartwatch alerts, often in asymptomatic individuals (subclinical AFib).
2. Subclinical AFib – What Does It Mean?
• Patients often feel anxiety without symptoms.
• The key question: Does early detection lead to better outcomes?
3. Treatment Basics:
• Traditional AFib treatment includes stroke risk assessment (CHA₂DS₂-VASc) and use of DOAC.
• Anticoagulants reduce stroke but increase bleeding risk.
4. Recent Trial Evidence:
• ARTESIA trial: Anticoagulants reduced stroke but increased major bleeding.
• NOAH-AFNET 6 trial: Minimal stroke reduction; bleeding risk still increased.
5. Computer Simulation Study (JAMA Network Open):
• Simulated 20,000 patients with subclinical AFib over 10 years.
• Blood thinners prevented 233 strokes, caused 453 major bleeds, and prevented 55 deaths.
• Net benefit: 9 days longer life and 9 days more quality-adjusted life per patient over 10 years.
6. Clinical Implication:
• Very modest benefit from treatment.
• For high-risk patients, benefit slightly better (11 days QALY gain).
• Raises question: Is it worth treating everyone with subclinical AFib?
7. Real-World Dilemma:
• Risk/benefit assessment is nuanced.
• Treating based on smartwatch alerts may lead to over-treatment in low-risk individuals.
• Psychological impact of “knowing” you have AFib can be significant.
8. Conclusion:
• There’s no strong case for routine anticoagulation in all subclinical AFib cases.
• Decisions should be individualized.
• The rise of consumer-driven diagnostics is disrupting the traditional risk-based treatment model.https://click.mail.medscape.com/?qs=3900ddeba56641e34c024648a96af8677e5b8fb96f8e9ace3bf94f9c790fee9271763ba2028328ce59b9f4d7d749251c511414b09943e4a28b58318ef7495bee
85 Views
7
Key Points Summary Title: Is a Year of Dual Antiplatelet Therapy Magical Thinking?May 22, 2025
Article summary : “Empowering Primary Care: Advanced Strategies for Cardiovascular Disease Management”May 22, 2025

مقالات ذات صلة

Uncategorized

FDA approved “Bumetanide” nasal spray for edema in CHF, kidney, and liver disease.

jordan heart September 18, 2025
Uncategorized

Can Jordan Create an AF CoE?

webadmin May 22, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • TAVR(TAVI in Europe)vs. SAVR —  Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients
  • Pediatric Cardiology: The LEAD Initiative — Universal Cholesterol Screening in Children Can Save Lives
  • Vericiguat in Heart Failure – VICTORIA vs VICTOR (ESC 2025)
  • Aspirin and Cancer Prevention
  • ‎‏ACC/AHA 2025 Update on Cost-Effectiveness in Clinical Practice Guidelines

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.